Levy; Julia G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Levy; Julia G..The latest application filed is for "ethylene glycol esters as photoactive agents".

Company Profile

0.30.12

Levy; Julia G. - Vancouver CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vision through photodynamic therapy of the eye Grant 8,239,978 - Strong , et al. August 14, 2	2012-08-14
Method for reducing or preventing PDT related inflammation Grant 8,106,038 - Margaron , et al. January 31, 2	2012-01-31
Immuno-adjuvant PDT treatment of metastatic tumors Grant 7,850,981 - Curry , et al. December 14, 2	2010-12-14
Ethylene Glycol Esters As Photoactive Agents App 20090203757 - STERNBERG; Ethan D. ; et al.	2009-08-13
Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases Grant 7,479,503 - Leong , et al. January 20, 2	2009-01-20
Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins App 20080096857 - Curaudeau; Alain H. ; et al.	2008-04-24
Ethylene glycol esters as photoactive agents App 20070191329 - Sternberg; Ethan D. ; et al.	2007-08-16
Ethylene glycol esters as photoactive agents Grant 7,122,569 - Sternberg , et al. October 17, 2	2006-10-17
Selective treatment of endothelial somatostatin receptors App 20060089299 - Hsiang; York ; et al.	2006-04-27
Immuno-adjuvant PDT treatment of metastatic tumors App 20050187207 - Curry, Patrick Mark ; et al.	2005-08-25
Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases App 20050130952 - Levy, Julia G. ; et al.	2005-06-16
Ethylene glycol esters as photoactive agents App 20050032769 - Sternberg, Ethan D. ; et al.	2005-02-10
Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases Grant 6,849,058 - Levy , et al. February 1, 2	2005-02-01
Ethylene glycol esters as photoactive agents Grant 6,756,396 - Sternberg , et al. June 29, 2	2004-06-29
Methods, compositions and articles for reducing or preventing the effects of inflammation Grant 6,677,366 - Richter , et al. January 13, 2	2004-01-13
Method to prevent xenograft transplant rejection Grant 6,659,107 - Obochi , et al. December 9, 2	2003-12-09
Method for reducing or preventing PDT related inflammation App 20030083649 - Margaron, Philippe Maria Clotaire ; et al.	2003-05-01
Method to prevent xenograft transplant App 20020139938 - Obochi, Modestus O.K. ; et al.	2002-10-03
Selective treatment of endothelial somatostatin receptors App 20020137676 - Hsiang, York ; et al.	2002-09-26
Methods, compositions and articles for reducing or preventing the effects of inflammation App 20020103180 - Richter, Anna M. ; et al.	2002-08-01
Method to prevent xenograft transplant rejection Grant 6,364,907 - Obochi , et al. April 2, 2	2002-04-02
Immuno-adjuvant PDT treatment of metastatic tumors App 20020022032 - Curry, Patrick Mark ; et al.	2002-02-21
Methods, compositions and articles for reducing or preventing the effects of inflammation Grant 6,274,614 - Richter , et al. August 14, 2	2001-08-14
Use of photodynamic therapy for prevention of secondary cataracts Grant 6,248,734 - Meadows , et al. June 19, 2	2001-06-19
Method for inhibiting apoptosis induced by photodynamic therapy using a cysteine or serine protease inhibitor Grant 6,180,402 - Granville , et al. January 30, 2	2001-01-30
Green porphyrins as immunomodulators Grant 6,107,325 - Chan , et al. August 22, 2	2000-08-22
Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases Grant 6,100,290 - Levy , et al. August 8, 2	2000-08-08
Use of photodynamic therapy for prevention of secondary cataracts Grant 6,043,237 - Meadows , et al. March 28, 2	2000-03-28
Method for destroying or inhibiting growth of unwanted cells or tissues Grant 5,945,439 - Richter , et al. August 31, 1	1999-08-31
Ethylene glycol esters as photoactive agents Grant 5,929,105 - Sternberg , et al. July 27, 1	1999-07-27
Method to prevent transplant rejection Grant 5,882,328 - Levy , et al. March 16, 1	1999-03-16
Method of activating photosensitive agents Grant 5,770,619 - Richter , et al. June 23, 1	1998-06-23
Method of activating photosensitive agents Grant 5,705,518 - Richter , et al. January 6, 1	1998-01-06
Method of treating skin diseases Grant 5,399,583 - Levy , et al. March 21, 1	1995-03-21
Wavelength-specific cytotoxic agents Grant 5,283,255 - Levy , et al. * February 1, 1	1994-02-01
Benzoporphyrin derivatives for photodynamic therapy Grant 5,214,036 - Allison , et al. May 25, 1	1993-05-25
Wavelength-specific cytotoxic agents Grant 5,171,749 - Levy , et al. December 15, 1	1992-12-15
Wavelength-specific cytotoxic agents Grant 5,095,030 - Levy , et al. * March 10, 1	1992-03-10
Method to destroy malignant cells in mononuclear cell populations Grant 5,087,636 - Jamieson , et al. February 11, 1	1992-02-11
Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents Grant 4,920,143 - Levy , et al. April 24, 1	1990-04-24
Method to stimulate the immune response to specific antigens Grant 4,898,730 - Levy , et al. February 6, 1	1990-02-06
Wavelength-specific cytotoxic agents Grant 4,883,790 - Levy , et al. November 28, 1	1989-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.